Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immucell (ICCC) Return on Equity (2016 - 2025)

Immucell (ICCC) has disclosed Return on Equity for 15 consecutive years, with 0.08% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 23.0% year-over-year to 0.08%, compared with a TTM value of 0.08% through Sep 2025, up 23.0%, and an annual FY2024 reading of 0.08%, up 13.0% over the prior year.
  • Return on Equity was 0.08% for Q3 2025 at Immucell, up from 0.06% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.08% in Q3 2025 and bottomed at 0.24% in Q3 2023.
  • Average Return on Equity over 5 years is 0.08%, with a median of 0.05% recorded in 2021.
  • The sharpest move saw Return on Equity dropped -22bps in 2023, then increased 23bps in 2025.
  • Year by year, Return on Equity stood at 0.0% in 2021, then plummeted by -3222bps to 0.08% in 2022, then crashed by -183bps to 0.23% in 2023, then soared by 65bps to 0.08% in 2024, then surged by 197bps to 0.08% in 2025.
  • Business Quant data shows Return on Equity for ICCC at 0.08% in Q3 2025, 0.06% in Q2 2025, and 0.01% in Q1 2025.